Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
PLoS Curr. 2010 Sep 2;2. pii: RRN1175. doi: 10.1371/currents.RRN1175.

KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic.

Author information

  • 1Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California, San Francisco, USA.

Abstract

KRAS mutational analysis is a genetic test used in clinical practice for determining the status of the KRAS gene (wild type or mutant) in tumors from patients with metastatic colorectal cancer (CRC). Persons whose tumors are wild type may respond to therapies cetuximab (Erbitux) or panitumumab (Vectibix).

PMID:
20877448
[PubMed]
PMCID:
PMC2940138
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Public Library of Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk